Detection of CBF beta/MYH11 fusion transcript: Value of minimal residual disease follow-up

被引：0
|
作者：
Costello, R
Cusenier, A
Sainty, D
Mozziconacci, MJ
Arnoulet, C
Blaise, D
Novakovitch, G
Maraninchi, D
Gastaut, JA
LafagePochitaloff, M
Gabert, J
机构：
[1] CTR CANC,DEPT BIOL,F-13009 MARSEILLE,FRANCE
[2] CTR CANC,DEPT CLIN HEMATOL,F-13009 MARSEILLE,FRANCE
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1996年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：825 / 825
页数：1
相关论文
共 50 条
  • [31] Conditioning and graft-versus-host disease decrease CBFβ/MYH11 fusion transcript monitored by quantitative PCR in patients with inv(16) AML after allogeneic haematopoietic stem cell transplantation
    Pinana, J. L.
    Valcarcel, D.
    Martino, R.
    Nomdedeu, J. F.
    Lasa, A.
    Aventin, A.
    Barba, P.
    Brunet, S.
    Sierra, J.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S337 - S337
  • [32] Evaluation of minimal residual disease (MRD) in inv(16) positive AMLS by qualitative and quantitative RT-PCR assays of CBFb/MYH11 fusion transcripts.
    Guerrasio, A
    De Micheli, D
    Pilatrino, C
    Gottardi, E
    Serra, A
    Tessore, N
    Volpe, G
    Marmont, F
    Melillo, L
    Diverio, D
    Lo Coco, F
    Saglio, G
    BLOOD, 2000, 96 (11) : 312A - 312A
  • [33] FLOW-CYTOMETRIC MULTIPLEX IMMUNOBEAD ASSAY FOR THE DETECTION OF CBFβ-MYH11 AND AML1-ETO FUSION PROTEINS IN ACUTE MYELOID LEUKEMIA
    Dekking, E.
    Velden, V.
    Boeckx, N.
    Sonneveld, E.
    Flores-Montero, J.
    Boettcher, S.
    Comans-Bitter, M.
    van Dongen, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 269 - 269
  • [34] Competitive CBFβ/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16):: A pilot study
    Laczika, K
    Novak, M
    Hilgarth, B
    Mitterbauer, M
    Mitterbauer, G
    Scheidel-Petrovic, A
    Scholten, C
    Thalhammer-Scherrer, R
    Brugger, S
    Keil, F
    Schwarzinger, I
    Haas, OA
    Lechner, K
    Jaeger, U
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1519 - 1525
  • [35] Detection of the PEBP2 beta/MYH11 fusion transcript in acute myelomonoblastic leukemia (M4Eo) supervening in a patient with adult T-cell leukemia
    Osato, M
    Asou, N
    Takata, N
    Suzushima, H
    Takatsuki, K
    Kawano, F
    AMERICAN JOURNAL OF HEMATOLOGY, 1997, 55 (04) : 216 - 217
  • [36] Detection of CBFβ/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation
    Elmaagacli, AH
    Beelen, DW
    Kroll, M
    Trzensky, S
    Stein, C
    Schaefer, UW
    BONE MARROW TRANSPLANTATION, 1998, 21 (02) : 159 - 166
  • [37] Molecular epidemiology and minimal residual disease (MRD) follow-up in childhood acute lymphoblastic leukemia (ALL) associated with fusion transcript expression:: A prospective single-center experience
    Baruchel, A
    Cayuela, JM
    Gényk, S
    Auclerc, MF
    Leblanc, T
    Schaison, G
    Sigaux, F
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 112 - 112
  • [38] Detection of CBFβ/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation
    AH Elmaagacli
    DW Beelen
    M Kroll
    S Trzensky
    C Stein
    UW Schaefer
    Bone Marrow Transplantation, 1998, 21 : 159 - 166
  • [39] RITUXIMAB AS TREATMENT FOR MINIMAL RESIDUAL DISEASE IN HAIRY CELL LEUKAEMIA: EXTENDED FOLLOW-UP
    Cervetti, G.
    Galimberti, S.
    Andreazzoli, F.
    Fazzi, R.
    Cecconi, N.
    Caracciolo, F.
    Petrini, M.
    HAEMATOLOGICA, 2008, 93 : S105 - S105
  • [40] Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow-up
    Cervetti, Giulia
    Galimberti, Sara
    Andreazzoli, Francesca
    Fazzi, Rita
    Cecconi, Nadia
    Caracciolo, Francesco
    Petrini, Mario
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (02) : 296 - 298
12345